Pages that link to "Q26991572"
Jump to navigation
Jump to search
The following pages link to Antibody responses to envelope glycoproteins in HIV-1 infection (Q26991572):
Displaying 50 items.
- The germinal center antibody response in health and disease (Q26745929) (← links)
- HIV Genome-Wide Protein Associations: a Review of 30 Years of Research (Q26746070) (← links)
- HIV-Host Interactions: Implications for Vaccine Design (Q26765966) (← links)
- Anergic B Cells: Precarious On-Call Warriors at the Nexus of Autoimmunity and False-Flagged Pathogens (Q26774672) (← links)
- Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection (Q26775082) (← links)
- Conformational Masking and Receptor-Dependent Unmasking of Highly Conserved Env Epitopes Recognized by Non-Neutralizing Antibodies That Mediate Potent ADCC against HIV-1 (Q26782237) (← links)
- The HIV glycan shield as a target for broadly neutralizing antibodies (Q26786540) (← links)
- Elimination of HIV-1-infected cells by broadly neutralizing antibodies (Q27329126) (← links)
- Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design (Q28075274) (← links)
- Perspectives for immunotherapy: which applications might achieve an HIV functional cure? (Q28078726) (← links)
- Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem (Q30234773) (← links)
- Survivors Remorse: antibody-mediated protection against HIV-1. (Q30238730) (← links)
- Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies. (Q30352300) (← links)
- Generation of Long-Lived Bone Marrow Plasma Cells Secreting Antibodies Specific for the HIV-1 gp41 Membrane-Proximal External Region in the Absence of Polyreactivity. (Q30391094) (← links)
- Engineering antibody-like inhibitors to prevent and treat HIV-1 infection (Q30490945) (← links)
- Clonify: unseeded antibody lineage assignment from next-generation sequencing data (Q31082802) (← links)
- Lessons learned from human HIV vaccine trials (Q33557844) (← links)
- Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System (Q33592852) (← links)
- Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance (Q33631104) (← links)
- Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters. (Q33638320) (← links)
- Antibody 10-1074 suppresses viremia in HIV-1-infected individuals (Q33786443) (← links)
- Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller (Q33786447) (← links)
- Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge (Q33804531) (← links)
- Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort (Q35894094) (← links)
- Spatiotemporal hierarchy in antibody recognition against transmitted HIV-1 envelope glycoprotein during natural infection (Q35925331) (← links)
- HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen (Q35969973) (← links)
- Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability (Q35985519) (← links)
- Discrete partitioning of HIV-1 Env forms revealed by viral capture. (Q36088254) (← links)
- HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects (Q36097352) (← links)
- Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants (Q36246646) (← links)
- Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1. (Q36263513) (← links)
- Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10. (Q36281210) (← links)
- A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds (Q36294782) (← links)
- Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization. (Q36334359) (← links)
- New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency (Q36433894) (← links)
- Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens (Q36434196) (← links)
- Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus (Q36450159) (← links)
- Host Anti-antibody Responses Following Adeno-associated Virus-mediated Delivery of Antibodies Against HIV and SIV in Rhesus Monkeys (Q36582838) (← links)
- Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. (Q36627503) (← links)
- CXCL13 is a plasma biomarker of germinal center activity (Q36684710) (← links)
- Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop (Q36694111) (← links)
- Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies (Q36725490) (← links)
- Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques (Q36736392) (← links)
- HIV-1 Antibody Neutralization Breadth Is Associated with Enhanced HIV-Specific CD4+ T Cell Responses (Q36736860) (← links)
- Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese Donor (Q36888400) (← links)
- High-Resolution Longitudinal Study of HIV-1 Env Vaccine-Elicited B Cell Responses to the Virus Primary Receptor Binding Site Reveals Affinity Maturation and Clonal Persistence. (Q36905471) (← links)
- Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques (Q37021717) (← links)
- Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques. (Q37025857) (← links)
- HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant (Q37059216) (← links)
- Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles (Q37060947) (← links)